News Between Reporter

Numerous film organizations, festivals, and freedom of speech NGOs have joined forces to advocate for the immediate dismissal of all charges against directors Maryam Moghadam and Behtash Sanaeeha. Additionally, they call for the lifting of the travel ban imposed on the filmmakers by Iranian authorities. Notable signatories include the Berlinale, the International Coalition for Filmmakers
0 Comments
Microsoft has recently announced a significant partnership with Suno to introduce AI-powered music creation capabilities to its popular AI assistant, Copilot. This collaboration aims to provide Copilot users with personalized song creation features using prompts and AI technology. Microsoft Copilot has undergone various enhancements driven by AI technologies in the recent past. In a move
0 Comments
FedEx, the renowned package delivery giant, experienced a significant drop in its shares, plummeting over 9% in after-hours trading on Tuesday. The company revised its revenue forecast due to weaker demand, which has impacted sales. This article delves into the reasons behind this decline, analyzes the company’s financial performance, and explores the potential implications for
0 Comments
ESG investing, which emphasizes environmental, social, and corporate governance criteria in portfolio construction, has long grappled with transparency issues and varying metrics across companies. This has made it challenging for investors to assess the impact of their investments accurately. However, San Francisco-based asset manager Newday Impact Investing believes it has found a potential solution. By
0 Comments
ZTE’s sub-brand, Nubia, has recently launched the highly anticipated Nubia Z60 Ultra. This flagship smartphone comes equipped with the powerful Snapdragon 8 Gen 3 SoC, making it an impressive contender in the market. With its stunning OLED display, massive battery capacity, and impressive camera setup, the Nubia Z60 Ultra is set to captivate users. Let’s
0 Comments
Women with inflammatory bowel disease (IBD) or relapsing multiple sclerosis (RMS) who become pregnant while taking the sphingosine-1-phosphate (S1P) receptor modulator ozanimod (Zeposia) may not be at a higher risk of complications, according to a recent study. Despite previous warnings against pregnancy while on the drug, researchers found that there was no increased incidence of
0 Comments